NYUTron is capable of being extended to multiple clinical and operational tasks. Figure2band Fig.2cshow that, on prediction tasks (in-hospital mortality, readmission, LOS and insurance denial), NYUTron had an area under the curve (AUC) of 78.7–94.9%, with an improvement of 5.36–14.7% in...